Mode
Text Size
Log in / Sign up

Systematic review and meta-analysis reports 36.6% cognitive impairment prevalence in coronary heart disease patients

Systematic review and meta-analysis reports 36.6% cognitive impairment prevalence in coronary…
Photo by Ecliptic Graphic / Unsplash
Key Takeaway
Consider age, stroke history, and smoking as risk factors for cognitive impairment in CHD patients.

This systematic review and meta-analysis examines the prevalence of cognitive impairment and associated risk factors among patients with coronary heart disease. The analysis included data from 9,207 patients to determine the overall burden of cognitive dysfunction in this population.

The primary outcome showed a pooled prevalence of cognitive impairment at 36.6% (95% CI 27.6%–45.7%). Several specific risk factors were evaluated to understand their contribution to cognitive decline in these patients.

Age was identified as a risk factor with an odds ratio of 1.10 (95% CI 1.04–1.17, P = 0.001). A history of stroke was associated with an odds ratio of 1.99 (95% CI 1.09–3.62, P = 0.02). Smoking showed the strongest association with an odds ratio of 3.05 (95% CI 2.00–4.66, P = value not reported).

The review did not report adverse events, discontinuations, or tolerability data. Because the study synthesizes observational data, causal language is avoided. The findings provide a reference for the implementation of targeted interventions but require cautious interpretation regarding clinical management.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BackgroundThe prevalence and risk factors of cognitive impairment in patients with coronary atherosclerotic heart disease (CHD) vary substantially depending on the measurement approaches and time points adopted. Through a meta-analysis, we aim to clarify the prevalence and risk factors of cognitive impairment in CHD patients, thereby providing a reference for the implementation of targeted interventions.MethodsComputerized searches were conducted across 9 databases, including the China National Knowledge Infrastructure (CNKI), VIP Database, Wanfang Database, China Biomedical Literature Database (CBM), PubMed, Cochrane Library, Embase, Medline, and Web of Science, to retrieve literature on risk factors for cognitive impairment in patients with coronary heart disease (CHD). Searches were run from database inception to July 2025. After literature screening, data extraction and quality assessment, a meta-analysis was performed using Stata 16.0 and RevMan 5.4 software.ResultsA total of 22 studies were included, involving 9,207 patients. The prevalence of cognitive impairment in CHD patients was 36.6% [95% CI (27.6%–45.7%)]. Meta-analysis and systematic review revealed that age [OR: 1.10 (1.04–1.17), P = 0.001], history of stroke [OR: 1.99 (1.09–3.62), P = 0.02], smoking [OR: 3.05 (2.00–4.66), P 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.